The 10 Friendliest Cities in the U.S.
The friendliest city for visitors is Honolulu, according to more than 6,400 respondents in a newly released poll by Travelzoo.
Survey takers were asked to pick the cities, states and countries where they felt the most welcome, could easily ask for directions, and get dining recommendations. New York City came in second, followed by New Orleans.
Last year was a record-breaking year for tourism, and the numbers confirm the popularity of these destinations for travelers. In 2014, 8.3 million visitors came to the Aloha State, with total visitor expenditures estimated at $14.7 billion. On average, 205,044 visitors are in the state of Hawaii on any given day.
Related: They’re Leaving Las Vegas: Fewer I Do’s in Last Decade
New York City, where tourism also hit a record high in 2014 with 56.4 million visitors streaming into the Big Apple, claimed the second spot in the poll.
Third place New Orleans has 9.52 million visitors and tourism spending of $6.81 billion in 2014. Fourth place Las Vegas also broke tourism records with 40 million visitors last year, thanks to renovated and rebranded resorts and direct flights from Canada and Mexico. Boston rounded out the top five, with a total of 16,250,000 international and domestic visitors in 2014.
Here are the top 10 friendly cities:
- Honolulu
- New York
- New Orleans
- Las Vegas
- Boston
- San Diego
- San Francisco
- Charleston, S.C.
- Chicago
- Seattle
Travelzoo also ranked states for friendliness, with warm climes dominating the list. In the top spot was Florida, followed by California and Hawaii. New York and Maine were the only states from the Northeast to make the list.
- Florida
- California
- Hawaii
- New York
- Texas
- South Carolina
- Maine
- Georgia
- Washington
- Arizona
In Europe, Amsterdam, London, and Dublin were considered the friendliest cities to visit, with Italy and Ireland seen as the friendliest countries.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
